World Library  
Flag as Inappropriate
Email this Article

Proteon Therapeutics

Article Id: WHEBN0018611445
Reproduction Date:

Title: Proteon Therapeutics  
Author: World Heritage Encyclopedia
Language: English
Subject: Aderis Pharmaceuticals, Qualitest, Cortex Pharmaceuticals, S. E. Massengill Company, Norwich Pharma Services
Publisher: World Heritage Encyclopedia

Proteon Therapeutics

Proteon Therapeutics
Type Private
Industry Pharmaceuticals

Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.

It is developing PRT-201, a drug to improve blood flow following vascular surgery procedures, and, more broadly, is interested in vascular access for hemodialysis and peripheral arterial disease (PAD). On September 10, 2008, Proteon announced that the Food and Drug Administration had granted fast track status to PRT-201.

Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include MPM Capital, Rockhill Partners, TVM Capital, Skyline Ventures, Prism VentureWorks, Vectis Life Sciences and Intersouth Partners. They have invested over $72 million in the company.[1]

On March 5, 2009, the company announced that it had raised $32 million from its existing investors plus MPM Capital and Vectis Life Sciences. Proteon also announced that it had entered into an option agreement to be acquired by Novartis for up to $550 million.[2]


  1. ^ Roberts, Rob (April 5, 2007). "Proteon secures $12M in financing". Kansas City Business Journal. Retrieved 2008-07-27. 
  2. ^ "Proteon raises $38m, signs option deal with Novartis". The Boston Globe. March 5, 2009. 
  • Roberts, Rob (April 5, 2007). "Proteon secures $12M in financing". Kansas City Business Journal. Retrieved 2008-07-27. 
  • McBride, Ryan (April 7, 2008). "Proteon chief pulls the GelTex band back together". MHT Mass High Tech. Retrieved 2008-07-27. 

External links

  • Official website

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.